Related references
Note: Only part of the references are listed.Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies
Kazuya Kariyama et al.
LIVER CANCER (2020)
Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients
Zhang Zhaohui et al.
CANCER RESEARCH AND TREATMENT (2019)
Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma
Shuling Chen et al.
CANCER MEDICINE (2019)
Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies
Myung Han Hyun et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis
Lei Liang et al.
HPB (2018)
Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series data
Lujun Shen et al.
NATURE COMMUNICATIONS (2018)
Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma
Wen-xin Wei et al.
INTERNATIONAL JOURNAL OF SURGERY (2018)
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Jian Zhou et al.
LIVER CANCER (2018)
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
David J. Pinato et al.
JOURNAL OF HEPATOLOGY (2017)
New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization
Jin Hyoung Kim et al.
LIVER INTERNATIONAL (2017)
Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan
Toshifumi Tada et al.
CANCER SCIENCE (2017)
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New
Luca Faloppi et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)
Ming-Chih Ho et al.
LIVER CANCER (2016)
When to Perform Hepatic Resection for Intermediate-Stage Hepatocellular Carcinoma
Alessandro Cucchetti et al.
HEPATOLOGY (2015)
Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma
Jing-Houng Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
Xavier Adhoute et al.
JOURNAL OF HEPATOLOGY (2015)
The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE
Florian Hucke et al.
JOURNAL OF HEPATOLOGY (2014)
Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions
Luigi Bolondi et al.
SEMINARS IN LIVER DISEASE (2012)
Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer:: Association with hypoxia-inducible factor (HIF-1α) pathway, angiogenic factors production and poor prognosis
Yanislav Kolev et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Prognostic prediction and treatment strategy in hepatocellular carcinoma
J Bruix et al.
HEPATOLOGY (2002)
Share Paper
